In the article “Deoxycytidine Kinase (DCK) Mutations in Human Acute Myeloid Leukemia Resistant to Cytarabine” [Acta Haematol. 2021;144:534–541, DOI: 10.1159/000513696] by Wu et al., the Funding Sources were not correctly given. The Funding Sources should read as follows:
Funding Sources
Supported by the NSFC Projects (No. 81570132 and No. 81873437, to Dr. Bin Yin), by the Natural Science Foundation of Jiangsu Province (No. BK20181130, to Dr. Bin Yin), by the Taihu Top-tier Medical Team Project (to the Dept Neurosurgery of Wuxi 2nd People’s Hospital), by grants of Science and Technology Development Fund of Nanjing medical university (No. 2017NJMUZD113) and the young talents of the enhanced health engineering of Wuxi science education (No. QNRC100, to Dr. Biao Wu) and Wuxi Medical Innovation Team (No. CXTDJS002, to Dr. Zhi Wang). RPG acknowledges support from the National Institute of Health Research (NIHR) Biomedical Research Centre funding scheme.